Inventor · disambiguated record
Patrick Hossler
Also filed as: HOSSLER PATRICK · HOSSLER PATRICK M · HOSSLER PATRICK MICHAEL
13 granted patents·11 pending applications·125 citations·filing 2010–2024
91Inventor score
Top patents by PatentIndex Score
24 records- 0197US9365645B1Methods for controlling the galactosylation profile of recombinantly-expressed proteinsABBVIE INC·Filed 2016·Granted Jun 14, 2016·18 cites·30 claims
- 0296US9255143B2Methods for controlling the galactosylation profile of recombinantly-expressed proteinsABBVIE INC·Filed 2015·Granted Feb 9, 2016·17 cites·21 claims
- 0396US9090688B2Methods for controlling the galactosylation profile of recombinantly-expressed proteinsABBVIE INC·Filed 2014·Granted Jul 28, 2015·29 cites·48 claims
- 0494US9062106B2Methods for controlling the galactosylation profile of recombinantly-expressed proteinsBENGEA CORNELIA·Filed 2012·Granted Jun 23, 2015·35 cites·65 claims
- 0592US11965032B1Anti-CD20 antibody compositionsTG THERAPEUTICS INC·Filed 2023·Granted Apr 23, 2024·2 cites·18 claims
- 0692US9505834B2Methods for controlling the galactosylation profile of recombinantly-expressed proteinsABBVIE INC·Filed 2016·Granted Nov 29, 2016·5 cites·30 claims
- 0791US11884740B1Anti-CD20 antibody compositionsTG THERAPEUTICS INC·Filed 2022·Granted Jan 30, 2024·2 cites·15 claims
- 0891US11807689B1Anti-CD20 antibody compositionsTG THERAPEUTICS INC·Filed 2022·Granted Nov 7, 2023·2 cites·22 claims
- 0989US11814439B1Anti-CD20 antibody compositionsTG THERAPEUTICS INC·Filed 2022·Granted Nov 14, 2023·2 cites·19 claims
- 1088US9499614B2Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharidesABBVIE INC·Filed 2014·Granted Nov 22, 2016·11 cites·22 claims
- 1177US2024209110A1Anti-cd20 antibody compositionsTG THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1277US2024270863A1Anti-cd20 antibody compositionsTG THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1368US9416181B2Compositions for cell culture and methods of using the sameABBVIE INC·Filed 2014·Granted Aug 16, 2016·1 cites·22 claims
- 1463US2017051052A1Methods for controlling the galactosylation profile of recombinantly-expressed proteinsABBVIE INC·Filed 2016·Application pending·0 cites
- 1560US9068970B2Efficient and effective supplement screening for the development of chemically defined media in cell cultureHOSSLER PATRICK·Filed 2011·Granted Jun 30, 2015·1 cites·6 claims
- 1657US2014271633A1Mammalian cell culture performance through surfactant supplementation of feed mediaABBVIE INC·Filed 2014·Application pending·0 cites
- 1757US2019185897A1Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharidesABBVIE INC·Filed 2018·Application pending·0 cites
- 1855US2014004531A1Secretory Protein Biomarkers For High Efficiency Protein ExpressionABBVIE INC·Filed 2013·Application pending·0 cites
- 1954US2017137860A1Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharidesABBVIE INC·Filed 2016·Application pending·0 cites
- 2052US2017355760A1Methods for modulating the glycosylation profile of recombinant proteins using sugarsABBVIE INC·Filed 2017·Application pending·0 cites
- 2148US2017247445A1Mammalian cell culture performance through surfactant supplementation of feed mediaABBVIE INC·Filed 2017·Application pending·0 cites
- 2247US8524458B2Secretory protein biomarkers for high efficiency protein expressionHOSSLER PATRICK·Filed 2010·Granted Sep 3, 2013·0 cites·16 claims
- 2345US2016185848A1Methods for modulating the glycosylation profile of recombinant proteins using sugarsABBVIE INC·Filed 2015·Application pending·0 cites
- 2434US2017226552A1Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using cobaltABBVIE INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrick Hossler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →